FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Ferrara

Research Profile

Disorders

Procedures

Living Beings

Anatomy

Chemicals & Drugs

Physiology

Lymphocyte Activation

Concepts & Ideas

T-Lymphocyte Subsets

Co-author Network

Publications

TOP 3
Andrew C Harris; James L M Ferrara; John E Levine
Advances in predicting acute GVHD.
Andrew C Harris; John E Levine; James L M Ferrara
Have we made progress in the treatment of GVHD?
Sung Won Choi; Kenneth Cooke; James L M Ferrara; David Alan Hanauer; Carrie L Kitko; Thomas Braun; Shin Mineishi; Sophie Paczesny; Attaphol Pawarode; Edward M Peres; Pavan Reddy; Tulio Rodriguez; Scott Smith; Patrick Stiff; Gregory Yanik; John E Levine
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Ferrara (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Andrew C Harris; James L M Ferrara; John E Levine
Advances in predicting acute GVHD.
British journal of haematology 2013;160(3):288-302.
2012: Andrew C Harris; John E Levine; James L M Ferrara
Have we made progress in the treatment of GVHD?
Best practice & research. Clinical haematology 2012;25(4):473-8.
2012: Sung Won Choi; Kenneth Cooke; James L M Ferrara; David Alan Hanauer; Carrie L Kitko; Thomas Braun; Shin Mineishi; Sophie Paczesny; Attaphol Pawarode; Edward M Peres; Pavan Reddy; Tulio Rodriguez; Scott Smith; Patrick Stiff; Gregory Yanik; John E Levine
TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(10):1525-32.
2012: Daniel R Wahl; Anthony William Opipari Jr; Craig A Byersdorfer; James L M Ferrara; Gary D Glick
Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation.
Immunological reviews 2012;249(1):104-15.
2012: John E Levine; Brent R Logan; Daniel J Weisdorf; Juan Wu; Amin Alousi; F. JAVIER BOLANOS MEADE; James L M Ferrara; Vincent T Ho; Sophie Paczesny
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.
Blood 2012;119(16):3854-60.
2012: Andrew C Harris; Ernst Holler; Karin Landfried; John E Levine; Koichi Akashi; Thomas M Braun; Sung Won Choi; Daniel Couriel; James L M Ferrara; Pavan Reddy; Takanori Teshima; Mark Vander Lugt; Sophie Paczesny
Plasma biomarkers of lower gastrointestinal and liver acute GVHD.
Blood 2012;119(12):2960-3.
2011: James L M Ferrara; Thomas M Braun; John E Levine; Karin Landfried; Sung W J Choi; Koichi Akashi; Ernst Holler; Andrew C Harris; Samir Hanash; Pavan Reddy; Alice Chin; Qing Zhang; Mark Vander Lugt; Elisabeth Huber; Joel K Greenson; Takanori Teshima; Sophie Paczesny
Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.
Blood 2011;118(25):6702-8.
2011: John Magenau; Sophie Paczesny; Attaphol Pawarode; Edward M Peres; Pavan Reddy; Jennifer Sanks; Hiromi Tobai; Gregory Yanik; Thomas Braun; Sung Won Choi; Kojo Seys John Elenitoba-Johnson; Harry P Erba; James L M Ferrara; David Frame; Andrew Harris; Dawn Jones; Carrie L Kitko; Lisa Ann Kujawski; John E Levine; Shin Mineishi
Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.
Blood 2011;118(15):4258-64.
2011: Erin Gatza; Daniel R Wahl; Anthony William Opipari Jr; Thomas B Sundberg; Pavan Reddy; Chen Liu; Gary D Glick; James L M Ferrara
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease.
Science translational medicine 2011;3(67):67ra8.
2010: James L M Ferrara; Pavan Reddy; Sophie Paczesny
Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.
Immunotherapy 2010;2(6):791-4.
2010: John M Magenau; Xuemei Qin; Isao Tawara; Clare E Rogers; Carrie L Kitko; Matthew Schlough; Daniel Bickley; Thomas M Braun; Pil-Sang Jang; Kathleen Price Lowler; Dawn M Jones; Sung Won Choi; Pavan Reddy; Shin Mineishi; John E Levine; James L M Ferrara; Sophie Paczesny
Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(7):907-14.
2010: Koji Kato; Shuaiying Cui; Rork Kuick; Shin Mineishi; Elizabeth Hexner; James L M Ferrara; Stephen G Emerson; Yi Zhang
Identification of stem cell transcriptional programs normally expressed in embryonic and neural stem cells in alloreactive CD8+ T cells mediating graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(6):751-71.
2010: Sung Won Choi; John E Levine; James L M Ferrara
Pathogenesis and management of graft-versus-host disease.
Immunology and allergy clinics of North America 2010;30(1):75-101.
2010: Sophie Paczesny; Thomas M Braun; John E Levine; Jason Hogan; Jeffrey Crawford; Bryan Coffing; Stephen H Olsen; Sung Won Choi; Hong Wang; Vitor Faca; Sharon Pitteri; Qing Zhang; Alice Chin; Carrie L Kitko; Shin Mineishi; Gregory Yanik; Edward M Peres; David Alan Hanauer; Ying Wang; Pavan Reddy; Samir Hanash; James L M Ferrara
Elafin is a biomarker of graft-versus-host disease of the skin.
Science translational medicine 2010;2(13):13ra2.
2010: Hojjat Salmasian; Mersedeh Rohanizadegan; Setareh Banihosseini; Raheleh Rahimi Darabad; Mahtab Rabbani-Anari; Alia Shakiba; James L M Ferrara
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation.
Cochrane database of systematic reviews (Online) 2010;(1):CD005565.
2009: Sophie Paczesny; Sung Won Choi; James L M Ferrara
Acute graft-versus-host disease: new treatment strategies.
Current opinion in hematology 2009;16(6):427-36.
2009: Robert Knobler; Mark L Barr; Daniel Couriel; James L M Ferrara; Lars E French; Peter Jaksch; Walter Reinisch; Alain H Rook; Thomas Schwarz; Hildegard Greinix
Extracorporeal photopheresis: past, present, and future.
Journal of the American Academy of Dermatology 2009;61(4):652-65.
2009: James L M Ferrara; John E Levine; Pavan Reddy; Ernst Holler
Graft-versus-host disease.
Lancet 2009;373(9674):1550-61.
2009: Sophie Paczesny; Oleg I Krijanovski; Thomas M Braun; Sung Won Choi; Shawn G Clouthier; Rork Kuick; David E Misek; Kenneth R Cooke; Carrie L Kitko; Angela Weyand; Daniel Bickley; Dawn Jones; Joel Whitfield; Pavan Reddy; John E Levine; Samir M Hanash; James L M Ferrara
A biomarker panel for acute graft-versus-host disease.
Blood 2009;113(2):273-8.
2009: Sophie Paczesny; John E Levine; Thomas M Braun; James L M Ferrara
Plasma biomarkers in graft-versus-host disease: a new era?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1 Suppl):33-8.
2008: James L M Ferrara
Advances in the clinical management of GVHD.
Best practice & research. Clinical haematology 2008;21(4):677-82.
2008: Gregory Yanik; Vincent T Ho; John E Levine; Eric White; Thomas Braun; Joseph H Antin; Joel Whitfield; Joseph R Custer; Dawn Jones; James L M Ferrara; Kenneth R Cooke
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Blood 2008;112(8):3073-81.
2008: John E Levine; Bruce R Blazar; Todd E DeFor; James L M Ferrara; Daniel J Weisdorf
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):1017-21.
2008: Sung Won Choi; Carrie L Kitko; Thomas Braun; Sophie Paczesny; Gregory Yanik; Shin Mineishi; Oleg Krijanovski; Dawn Jones; Joel Whitfield; Kenneth Cooke; Raymond J Hutchinson; James L M Ferrara; John E Levine
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.
Blood 2008;112(4):1539-42.
2008: Erin Gatza; Clare E Rogers; Shawn G Clouthier; Kathleen Price Lowler; Isao Tawara; Chen Liu; Pavan Reddy; James L M Ferrara
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells.
Blood 2008;112(4):1515-21.
2008: Pavan Reddy; Yi Sun; Tomomi Toubai; Raimon Duran-Struuck; Shawn G Clouthier; Elizabeth Weisiger; Yoshinobu Maeda; Isao Tawara; Oleg Krijanovski; Erin Gatza; Chen Liu; Chelsea Malter; Paolo Mascagni; Charles A Dinarello; James L M Ferrara
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.
The Journal of clinical investigation 2008;118(7):2562-73.
2008: Carrie L Kitko; Sophie Paczesny; Gregory Yanik; Thomas Braun; Dawn Jones; Joel Whitfield; Sung Won Choi; Raymond J Hutchinson; James L M Ferrara; John E Levine
Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):759-65.
2008: Michael A Flierl; Daniel Rittirsch; Hongwei Gao; Laszlo M Hoesel; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus Huber-Lang; James L M Ferrara; Peter A Ward
Adverse functions of IL-17A in experimental sepsis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(7):2198-205.
2008: Mwe Mwe Chao; John E Levine; James L M Ferrara; Laura Cooling; Kenneth R Cooke; Raymond J Hutchinson; Gregory Yanik
Successful treatment of refractory immune hemolysis following unrelated cord blood transplant with Campath-1H.
Pediatric blood & cancer 2008;50(4):917-9.
2008: John E Levine; Sophie Paczesny; Shin Mineishi; Thomas Braun; Sung Won Choi; Raymond J Hutchinson; Dawn Jones; Yasser A Khaled; Carrie L Kitko; Daniel Bickley; Oleg Krijanovski; Pavan Reddy; Gregory Yanik; James L M Ferrara
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
Blood 2008;111(4):2470-5.
2007: Raimon Duran-Struuck; Isao Tawara; Kathleen Price Lowler; Shawn G Clouthier; Elizabeth Weisiger; Clare Rogers; Gary D Luker; Atsushi Kumanogoh; Chen Liu; James L M Ferrara; Pavan Reddy
A novel role for the semaphorin Sema4D in the induction of allo-responses.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1294-1303.
2007: James L M Ferrara; Claudio Anasetti; Edward Stadtmauer; Joseph H Antin; John Wingard; Stephanie Lee; John E Levine; Kirk R Schultz; Frederick Appelbaum; Robert Negrin; Sergio Giralt; Christopher N Bredeson; Helen Heslop; Mary Horowitz
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1268-85.
2007: Eva M Weissinger; Eric Schiffer; Bernd Hertenstein; James L M Ferrara; Ernst Holler; Michael Stadler; Hans-Jochem Kolb; Axel Zander; Petra Zürbig; Markus Kellmann; Arnold Ganser
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Blood 2007;109(12):5511-9.
2007: Yasser A Khaled; K Kato; N Janakiraman; James L M Ferrara; Shin Mineishi
Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma.
Bone marrow transplantation 2007;39(11):727-8.
2007: James L M Ferrara
Novel strategies for the treatment and diagnosis of graft-versus-host-disease.
Best practice & research. Clinical haematology 2007;20(1):91-7.
2007: Mohamed A Kharfan-Dabaja; Claudio Anasetti; James L M Ferrara
Sympathectomy protects denervated skin from graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):369-70.
2007: Daniel Weisdorf; Shelly Carter; Dennis L Confer; James L M Ferrara; Mary Horowitz
Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):257-62; discussion 255-6.
2006: Bruce R Blazar; Daniel J Weisdorf; Todd E DeFor; Anne Goldman; Thomas Braun; Samuel Michael Silver; James L M Ferrara
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).
Blood 2006;108(9):3216-22.
2006: Hildegard T Greinix; G Socié; A Bacigalupo; E Holler; M G Edinger; J F Apperley; T Schwarz; Stephen Ullrich; M L Albert; Robert Knobler; David Peritt; James L M Ferrara
Assessing the potential role of photopheresis in hematopoietic stem cell transplant.
Bone marrow transplantation 2006;38(4):265-73.
2006: Javaneh Abbasian; Dolores Mahmud; Nadim Mahmud; Sandeep Chunduri; Hiroto Araki; Pavan Reddy; Ronald Hoffman; Mario Arpinati; James L M Ferrara; Damiano Rondelli
Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function.
Blood 2006;108(1):203-8.
2006: J Douglas Rizzo; John R Wingard; André Tichelli; Su-Jun Lee; Maria Teresa Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):138-51.
2006: Kirk R Schultz; David B Miklos; Daniel Fowler; Ken Cooke; Judith A Shizuru; Emmanuel Zorn; Ernst Holler; James L M Ferrara; Howard M Shulman; Stephanie J Lee; Paul Martin; Alexandra H Filipovich; Mary E D Flowers; Daniel Weisdorf; Daniel Couriel; Peter A Lachenbruch; Barbara Mittleman; Georgia B Vogelsang; Steven Z Pavletic
Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):126-37.
2006: J Douglas Rizzo; John R Wingard; André Tichelli; Su-Jun Lee; M T Van Lint; Linda J Burns; Stella M Davies; James L M Ferrara; Gérard Socié
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Marrow Transplantation (EBMT/CIBMTR/ASBMT).
Bone marrow transplantation 2006;37(3):249-61.
2006: James L M Ferrara; Pavan Reddy
Pathophysiology of graft-versus-host disease.
Seminars in hematology 2006;43(1):3-10.
2006: James L M Ferrara; John E Levine
Graft-versus-host disease in the 21st century: new perspectives on an old problem.
Seminars in hematology 2006;43(1):1-2.
2005: Pavan Reddy; Yoshinobu Maeda; Chen Liu; Oleg I Krijanovski; Robert Korngold; James L M Ferrara
A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses.
Nature medicine 2005;11(11):1244-9.
2005: Sung Won Choi; S Islam; Joel K Greenson; John E Levine; Raymond J Hutchinson; Gregory Yanik; Daniel H Teitelbaum; James L M Ferrara; Kenneth R Cooke
The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(10):891-6.
2005: Adetola Kassim; Wichai Chinratanalab; James L M Ferrara; Shin Mineishi
Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.
Bone marrow transplantation 2005;36(7):565-74.
2005: Joseph Primo Uberti; Lois Jeanne Ayash; Voravit Ratanatharathorn; Samuel Michael Silver; Christopher Reynolds; Michael Becker; Pavan Reddy; Kenneth R Cooke; Gregory Yanik; Joel Whitfield; Dawn Jones; Raymond J Hutchinson; Thomas Braun; James L M Ferrara; John E Levine
Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):680-7.
2005: Adam S Hassan; Shawn G Clouthier; James L M Ferrara; Alexandra Stepan; Shahzad I Mian; Amjad Z Ahmad; Victor M Elner
Lacrimal gland involvement in graft-versus-host disease: a murine model.
Investigative ophthalmology & visual science 2005;46(8):2692-7.
2005: Vincent T Ho; Corey Cutler; Shelly Carter; Paul Martin; Roberta Adams; Mary Horowitz; James L M Ferrara; Robert J Soiffer; Sergio Giralt
Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(8):571-5.
2005: Yoshinobu Maeda; Pavan Reddy; Kathleen Price Lowler; Chen Liu; D Keith Bishop; James L M Ferrara
Critical role of host gammadelta T cells in experimental acute graft-versus-host disease.
Blood 2005;106(2):749-55.
2005: James L M Ferrara; Gregory Yanik
Acute graft versus host disease: pathophysiology, risk factors, and prevention strategies.
Clinical advances in hematology & oncology : H&O 2005;3(5):415-9, 428.
2005: Hong Wang; Shawn G Clouthier; Vladimir Galchev; David E Misek; Ulrich Duffner; Chang-Ki Min; Rong Zhao; John Tra; Gilbert S Omenn; James L M Ferrara; Samir M Hanash
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids.
Molecular & cellular proteomics : MCP 2005;4(5):618-25.
2005: Michael Sabel; Matthew A Nehs; Gang Su; Kathleen Price Lowler; James L M Ferrara; Alfred E Chang
Immunologic response to cryoablation of breast cancer.
Breast cancer research and treatment 2005;90(1):97-104.
2005: Sung Won Choi; Laurence A Boxer; Michael Allen Pulsipher; Diane Roulston; Raymond J Hutchinson; Gregory Yanik; Kenneth R Cooke; James L M Ferrara; John E Levine
Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation.
Bone marrow transplantation 2005;35(5):473-7.
2005: Yoshinobu Maeda; Robert B Levy; Pavan Reddy; Chen Liu; Shawn G Clouthier; Takanori Teshima; James L M Ferrara
Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease.
Blood 2005;105(5):2023-7.
2005: Kelli P A MacDonald; Vanessa Rowe; Andrew D Clouston; Joseph K Welply; Rachel D Kuns; James L M Ferrara; Ranjeny Thomas; Geoffrey R Hill
Cytokine expanded myeloid precursors function as regulatory antigen-presenting cells and promote tolerance through IL-10-producing regulatory T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):1841-50.
2005: Mark S Szczypka; Angela J Westover; Shawn G Clouthier; James L M Ferrara; H David Humes
Rare incorporation of bone marrow-derived cells into kidney after folic acid-induced injury.
Stem cells (Dayton, Ohio) 2005;23(1):44-54.
2004: Jeffery J Auletta; Jennifer L DeVecchio; James L M Ferrara; Frederick P Heinzel
Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):834-47.
2004: Chang-Ki Min; Yoshinobu Maeda; Kathleen Price Lowler; Chen Liu; Shawn G Clouthier; David Lofthus; Elizabeth Weisiger; James L M Ferrara; Pavan Reddy
Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Blood 2004;104(10):3393-9.
2004: Armin Gerbitz; Brian J Nickoloff; Krystyna M Olkiewicz; Nicole E Willmarth; Gerhard C Hildebrandt; Chen Liu; Lester Kobzik; Günther Eissner; Ernst Holler; James L M Ferrara; Kenneth R Cooke
A role for tumor necrosis factor-alpha-mediated endothelial apoptosis in the development of experimental idiopathic pneumonia syndrome.
Transplantation 2004;78(4):494-502.
2004: Ulrich Duffner; Yoshinobu Maeda; Kenneth R Cooke; Pavan Reddy; Rainer Ordemann; Chen Liu; James L M Ferrara; Takanori Teshima
Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 2004;172(12):7393-8.
2004: Kelli P A MacDonald; Vanessa Rowe; Cheryl Filippich; Diana Johnson; Edward S Morris; Andrew D Clouston; James L M Ferrara; Geoffrey R Hill
Chronic graft-versus-host disease after granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation: the role of donor T-cell dose and differentiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):373-85.
2004: Craig C Hofmeister; Adam Quinn; Kenneth R Cooke; Patrick J Stiff; Brian Nickoloff; James L M Ferrara
Graft-versus-host disease of the skin: life and death on the epidermal edge.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):366-72.
2004: Pavan Reddy; Yoshinobu Maeda; Kevin B Hotary; Chen Liu; Leonid L Reznikov; Charles A Dinarello; James L M Ferrara
Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(11):3921-6.
2004: Pavan Reddy; Robertson D Davenport; Voravit Ratanatharathorn; Christopher Reynolds; Samuel Michael Silver; Lois Jeanne Ayash; James L M Ferrara; Joseph Primo Uberti
West Nile virus encephalitis causing fatal CNS toxicity after hematopoietic stem cell transplantation.
Bone marrow transplantation 2004;33(1):109-12.
2003: Kenneth R Cooke; James L M Ferrara
A protective gene for graft-versus-host disease.
The New England journal of medicine 2003;349(23):2183-4.
2003: Thomas M Braun; John E Levine; James L M Ferrara
Determining a maximum tolerated cumulative dose: dose reassignment within the TITE-CRM.
Controlled clinical trials 2003;24(6):669-81.
2003: Pavan Reddy; James L M Ferrara
Immunobiology of acute graft-versus-host disease.
Blood reviews 2003;17(4):187-94.
2003: James L M Ferrara; Kenneth R Cooke; Takanori Teshima
The pathophysiology of acute graft-versus-host disease.
International journal of hematology 2003;78(3):181-7.
2003: Ulrich Duffner; Bao Lu; Gerhard C Hildebrandt; Takanori Teshima; Debra L Williams; Pavan Reddy; Rainer Ordemann; Shawn G Clouthier; Kathleen Price Lowler; Chen Liu; Craig Gerard; Kenneth R Cooke; James L M Ferrara
Role of CXCR3-induced donor T-cell migration in acute GVHD.
Experimental hematology 2003;31(10):897-902.
2003: Shawn G Clouthier; Kenneth R Cooke; Takanori Teshima; Kathleen Price Lowler; Chen Liu; Kevin Connolly; James L M Ferrara
Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(9):592-603.
2003: Voravit Ratanatharathorn; Lois Jeanne Ayash; Christopher Reynolds; Samuel Michael Silver; Pavan Reddy; Michael Becker; James L M Ferrara; Joseph Primo Uberti
Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(8):505-11.
2003: Tamotsu Ichiba; Takanori Teshima; Rork Kuick; David E Misek; Chen Liu; Yuichiro Takada; Yoshinobu Maeda; Pavan Reddy; Debra L Williams; Samir M Hanash; James L M Ferrara
Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.
Blood 2003;102(2):763-71.
2003: Takanori Teshima; Pavan Reddy; Chen Liu; Debra Williams; Kenneth R Cooke; James L M Ferrara
Impaired thymic negative selection causes autoimmune graft-versus-host disease.
Blood 2003;102(2):429-35.
2003: Pavan Reddy; James L M Ferrara
Role of interleukin-18 in acute graft-vs-host disease.
The Journal of laboratory and clinical medicine 2003;141(6):365-71.
2003: Pavan Reddy; Takanori Teshima; Gerhard C Hildebrandt; Debra L Williams; Chen Liu; Kenneth R Cooke; James L M Ferrara
Pretreatment of donors with interleukin-18 attenuates acute graft-versus-host disease via STAT6 and preserves graft-versus-leukemia effects.
Blood 2003;101(7):2877-85.
2003: John E Levine; Joseph Primo Uberti; Lois Jeanne Ayash; Christopher Reynolds; James L M Ferrara; Samuel Michael Silver; Thomas Braun; Gregory Yanik; Raymond J Hutchinson; Voravit Ratanatharathorn
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):189-97.
2003: Kelli P A MacDonald; Vanessa Rowe; Cheryl Filippich; Ranjeny Thomas; Andrew D Clouston; Joseph K Welply; Derek N J Hart; James L M Ferrara; Geoffrey R Hill
Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.
Blood 2003;101(5):2033-42.
2003: James L M Ferrara
Location, location, location.
Nature immunology 2003;4(2):103-4.
2002: Mark J DiNubile; Thomas P Stossel; Olof C Ljunghusen; James L M Ferrara; Joseph H Antin
Prognostic implications of declining plasma gelsolin levels after allogeneic stem cell transplantation.
Blood 2002;100(13):4367-71.
2002: Joseph H Antin; Daniel Weisdorf; Donna Neuberg; Roberta Nicklow; Shawn Clouthier; Stephanie J Lee; Edwin P Alyea; Carol McGarigle; Bruce R Blazar; Stephen Sonis; Robert J Soiffer; James L M Ferrara
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.
Blood 2002;100(10):3479-82.
2002: Pavan Reddy; Takanori Teshima; Gerhard C Hildebrandt; Ulrich Duffner; Yoshinobu Maeda; Kenneth R Cooke; James L M Ferrara
Interleukin 18 preserves a perforin-dependent graft-versus-leukemia effect after allogeneic bone marrow transplantation.
Blood 2002;100(9):3429-31.
2002: James L M Ferrara
Cellular and cytokine effectors of acute graft versus host disease.
International journal of hematology 2002;76 Suppl 1():195-8.
2002: Peter C Trask; A Paterson; Michelle B Riba; B Brines; Kent Andrew Griffith; P Parker; J Weick; P Steele; K Kyro; James L M Ferrara
Assessment of psychological distress in prospective bone marrow transplant patients.
Bone marrow transplantation 2002;29(11):917-25.
2002: Takanori Teshima; Rainer Ordemann; Pavan Reddy; Svetlana Gagin; Chen Liu; Kenneth R Cooke; James L M Ferrara
Acute graft-versus-host disease does not require alloantigen expression on host epithelium.
Nature medicine 2002;8(6):575-81.
2002: Shawn G Clouthier; James L M Ferrara; Takanori Teshima
Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation.
Transplantation 2002;73(10):1679-81.
2002: Rainer Ordemann; Raymond J Hutchinson; Jeffrey Friedman; Steven J Burakoff; Pavan Reddy; Ulrich Duffner; Thomas M Braun; Chen Liu; Takanori Teshima; James L M Ferrara
Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease.
The Journal of clinical investigation 2002;109(9):1249-56.
2002: Gregory Yanik; John E Levine; Katherine K Matthay; James C Sisson; Barry L Shulkin; Brahm Shapiro; David Hubers; Susan Spalding; Thomas Braun; James L M Ferrara; Raymond J Hutchinson
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2142-9.
2002: Joseph H Antin; Stephanie J Lee; Donna Neuberg; Edwin P Alyea; Robert J Soiffer; Stephen Sonis; James L M Ferrara
A phase I/II double-blind, placebo-controlled study of recombinant human interleukin-11 for mucositis and acute GVHD prevention in allogeneic stem cell transplantation.
Bone marrow transplantation 2002;29(5):373-7.
2002: Takanori Teshima; Pavan Reddy; Kathleen Price Lowler; Mark A KuKuruga; Chen Liu; Kenneth R Cooke; James L M Ferrara
Flt3 ligand therapy for recipients of allogeneic bone marrow transplants expands host CD8 alpha(+) dendritic cells and reduces experimental acute graft-versus-host disease.
Blood 2002;99(5):1825-32.
2002: Takanori Teshima; Chen Liu; Kathleen Price Lowler; Glenn Dranoff; James L M Ferrara
Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation.
Cancer research 2002;62(3):796-800.
2002: Kenneth R Cooke; Krystyna M Olkiewicz; Nicole Erickson; James L M Ferrara
The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease.
Journal of endotoxin research 2002;8(6):441-8.
2002: James L M Ferrara; Alvin H Schmaier
Hematology grants workshop.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():484-9.
2002: Gregory Yanik; Beth A Hellerstedt; Joseph R Custer; Raymond J Hutchinson; Deborah Kwon; James L M Ferrara; Joseph Primo Uberti; Kenneth R Cooke
Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):395-400.
2002: James L M Ferrara; John R Wingard
Clinical research: the best or worst of times?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(6):293-4.
2002: Takanori Teshima; James L M Ferrara
Understanding the alloresponse: new approaches to graft-versus-host disease prevention.
Seminars in hematology 2002;39(1):15-22.
2001: Pavan Reddy; Takanori Teshima; Mark A KuKuruga; Rainer Ordemann; Chen Liu; Kathleen Price Lowler; James L M Ferrara
Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis.
The Journal of experimental medicine 2001;194(10):1433-40.
2001: Lois Jeanne Ayash; M Clarke; P Adams; James L M Ferrara; Voravit Ratanatharathorn; C Reynolds; Blake J Roessler; Samuel Michael Silver; Myla S Strawderman; Joseph Primo Uberti; Max S Wicha
Clinical protocol. Purging of autologous stem cell sources with bcl-x(s) adenovirus for women undergoing high-dose chemotherapy for stage IV breast carcinoma.
Human gene therapy 2001;12(16):2023-5.
2001: Kenneth R Cooke; Armin Gerbitz; James M Crawford; Takanori Teshima; GR Hill; A Tesolin; D P Rossignol; James L M Ferrara
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.
The Journal of clinical investigation 2001;107(12):1581-9.
2001: Lois Jeanne Ayash; M Clarke; Samuel Michael Silver; Thomas Braun; Joseph Primo Uberti; Voravit Ratanatharathorn; Christopher Reynolds; James L M Ferrara; E R Broun; Paul T Adams
Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review.
Bone marrow transplantation 2001;27(9):939-47.
2001: Cornelius Schmaltz; Onder Alpdogan; KJ Horndasch; Stephanie J Muriglan; Barry J Kappel; T Teshima; James L M Ferrara; Steven J Burakoff; Marcel R M van den Brink
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.
Blood 2001;97(9):2886-95.
2001: Claudio S Padovan; Armin Gerbitz; Petra Sostak; Ernst Holler; James L M Ferrara; Karl Bise; Andreas Straube
Cerebral involvement in graft-versus-host disease after murine bone marrow transplantation.
Neurology 2001;56(8):1106-8.
2001: Christopher Reynolds; Voravit Ratanatharathorn; P Adams; Thomas Braun; Samuel Michael Silver; Lois Jeanne Ayash; E Carson; Avraham Eisbruch; Laura A Dawson; Kevin T McDonagh; James L M Ferrara; Joseph Primo Uberti
Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
Bone marrow transplantation 2001;27(8):801-7.
2001: Ronald van Os; TM Sheridan; S Robinson; D Drukteinis; James L M Ferrara; Peter M Mauch
Immunogenicity of Ly5 (CD45)-antigens hampers long-term engraftment following minimal conditioning in a murine bone marrow transplantation model.
Stem cells (Dayton, Ohio) 2001;19(1):80-7.
2001: Takanori Teshima; Nicolas Mach; GR Hill; L Pan; Silke Gillessen; Glenn Dranoff; James L M Ferrara
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation.
Cancer research 2001;61(1):162-71.
2000: Kenneth R Cooke; GR Hill; Armin Gerbitz; Lester Kobzik; T R Martin; James M Crawford; JP Brewer; James L M Ferrara
Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(11):6612-9.
2000: Voravit Ratanatharathorn; E Carson; Christopher Reynolds; Lois Jeanne Ayash; John E Levine; Gregory Yanik; Samuel Michael Silver; James L M Ferrara; Joseph Primo Uberti
Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease.
Annals of internal medicine 2000;133(4):275-9.
2000: Kenneth R Cooke; GR Hill; Armin Gerbitz; Lester Kobzik; T R Martin; James M Crawford; JP Brewer; James L M Ferrara
Tumor necrosis factor-alpha neutralization reduces lung injury after experimental allogeneic bone marrow transplantation.
Transplantation 2000;70(2):272-9.
2000: Gregory Yanik; John E Levine; Voravit Ratanatharathorn; R Dunn; James L M Ferrara; Raymond J Hutchinson
Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation.
Bone marrow transplantation 2000;26(2):161-7.
2000: James L M Ferrara
Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.
Journal of hematotherapy & stem cell research 2000;9(3):299-306.
2000: G R Hill; James L M Ferrara
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.
Blood 2000;95(9):2754-9.
2000: James L M Ferrara
Cytokines and the regulation of tolerance.
The Journal of clinical investigation 2000;105(8):1043-4.
2000: V Reddy; GR Hill; L Pan; Armin Gerbitz; Takanori Teshima; YS Brinson; James L M Ferrara
G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient.
Transplantation 2000;69(4):691-3.
2000: Marcel R M van den Brink; E Moore; James L M Ferrara; Steven J Burakoff
Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.
Transplantation 2000;69(3):446-9.
2000: GR Hill; Takanori Teshima; Vivienne Rebel; Oleg I Krijanovski; Kenneth R Cooke; YS Brinson; James L M Ferrara
The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(2):656-63.
2000: Ekkehard Sturm; T L Zimmerman; AR Crawford; SI Svetlov; P Sundaram; James L M Ferrara; Saul J Karpen; JM Crawford
Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell line.
Hepatology (Baltimore, Md.) 2000;31(1):124-30.
1999: Dianne B Mckay; Hanna Yoko Irie; G Hollander; James L M Ferrara; T B Strom; Y Li; Steven J Burakoff
Antigen-induced unresponsiveness results in altered T cell signaling.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(12):6455-61.
1999: Vivienne Rebel; S Hartnett; GR Hill; S B Lazo-Kallanian; James L M Ferrara; Colin A Sieff
Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level.
The Journal of experimental medicine 1999;190(10):1493-504.
1999: GR Hill; Takanori Teshima; Armin Gerbitz; L Pan; Kenneth R Cooke; YS Brinson; James M Crawford; James L M Ferrara
Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia.
The Journal of clinical investigation 1999;104(4):459-67.
1999: Takanori Teshima; GR Hill; L Pan; YS Brinson; Marcel R M van den Brink; Kenneth R Cooke; James L M Ferrara
IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
The Journal of clinical investigation 1999;104(3):317-25.
1999: Oleg I Krijanovski; GR Hill; Kenneth R Cooke; Takanori Teshima; James M Crawford; YS Brinson; James L M Ferrara
Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.
Blood 1999;94(2):825-31.
1999: GR Hill; Kenneth R Cooke; YS Brinson; D Bungard; James L M Ferrara
Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation.
Transplantation 1999;67(11):1478-80.
1999: L Pan; Takanori Teshima; GR Hill; D Bungard; YS Brinson; V S Reddy; Kenneth R Cooke; James L M Ferrara
Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantation maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host disease.
Blood 1999;93(12):4071-8.
1999: JA Grass; T Wafa; A Reames; David Wages; Laurence Corash; James L M Ferrara; Lily Lin
Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.
Blood 1999;93(9):3140-7.
1999: James L M Ferrara; E Holler; B Blazar
Monoclonal antibody and receptor antagonist therapy for GVHD.
Cancer treatment and research 1999;101():331-68.
1999: James L M Ferrara; Robert B Levy; N J Chao
Pathophysiologic mechanisms of acute graft-vs.-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):347-56.
1998: Kenneth R Cooke; GR Hill; James M Crawford; D Bungard; YS Brinson; J Delmonte; James L M Ferrara
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
The Journal of clinical investigation 1998;102(10):1882-91.
1998: Kenneth R Cooke; W Krenger; G Hill; T R Martin; L Kobzik; J Brewer; R Simmons; James M Crawford; Marcel R M van den Brink; James L M Ferrara
Host reactive donor T cells are associated with lung injury after experimental allogeneic bone marrow transplantation.
Blood 1998;92(7):2571-80.
1998: GR Hill; Kenneth R Cooke; Takanori Teshima; James M Crawford; James Carl Keith; YS Brinson; D Bungard; James L M Ferrara
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.
The Journal of clinical investigation 1998;102(1):115-23.
1998: James L M Ferrara
The cytokine modulation of acute graft-versus-host disease.
Bone marrow transplantation 1998;21 Suppl 3():S13-5.
1998: James L M Ferrara; W Krenger
Graft-versus-host disease: the influence of type 1 and type 2 T cell cytokines.
Transfusion medicine reviews 1998;12(1):1-17.
1998: K Dunussi-Joannopoulos; Glenn Dranoff; Howard J Weinstein; James L M Ferrara; BE Bierer; JM Croop
Gene immunotherapy in murine acute myeloid leukemia: granulocyte-macrophage colony-stimulating factor tumor cell vaccines elicit more potent antitumor immunity compared with B7 family and other cytokine vaccines.
Blood 1998;91(1):222-30.
1997: GR Hill; W Krenger; James L M Ferrara
The role of cytokines in acute graft-versus-host disease.
Cytokines, cellular & molecular therapy 1997;3(4):257-66.
1997: K K Ballen; D G Gilliland; Eva C Guinan; C C Hsieh; Susan K Parsons; I J Rimm; James L M Ferrara; BE Bierer; Howard J Weinstein; Joseph H Antin
Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia.
Bone marrow transplantation 1997;20(9):737-43.
1997: GR Hill; James M Crawford; Kenneth R Cooke; YS Brinson; L Pan; James L M Ferrara
Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.
Blood 1997;90(8):3204-13.
1997: Kenneth R Cooke; R Nishinakamura; T R Martin; L Kobzik; J Brewer; J A Whitsett; D Bungard; R Murray; James L M Ferrara
Persistence of pulmonary pathology and abnormal lung function in IL-3/GM-CSF/IL-5 beta c receptor-deficient mice despite correction of alveolar proteinosis after BMT.
Bone marrow transplantation 1997;20(8):657-62.
1997: W Krenger; GR Hill; James L M Ferrara
Cytokine cascades in acute graft-versus-host disease.
Transplantation 1997;64(4):553-8.
1997: C Wheeler; C Eickhoff; A Elias; Joseph G Ibrahim; Lois Jeanne Ayash; Mary McCauley; Peter M Mauch; Gary Schwartz; Joseph P Eder; R Mazanet; James L M Ferrara; I J Rimm; Eva C Guinan; BE Bierer; G Gilliland; Winthrop H Churchill; K Ault; S Parsons; Karen Antman; Lowell E Schnipper; I Tepler; L Gaynes; Emil Frei; Marshall E Kadin; Joseph H Antin
High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(2):98-106.
1997: K Dunussi-Joannopoulos; W Krenger; Howard J Weinstein; James L M Ferrara; JM Croop
CD8+ T cells activated during the course of murine acute myelogenous leukemia elicit therapeutic responses to late B7 vaccines after cytoreductive treatment.
Blood 1997;89(8):2915-24.
1997: Hubert Schwaighofer; G Oberhuber; H Hebart; Hermann Einsele; Manfred Herold; David Nachbaur; Brigitte Eibl; Herbert Tilg; Gabriele Kropshofer; James L M Ferrara; Dietger Niederwieser
Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy.
Transplantation 1997;63(1):52-6.
1996: W Krenger; Kenneth R Cooke; J M Crawford; S T Sonis; R Simmons; L Pan; J Delmonte; M Karandikar; James L M Ferrara
Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease.
Transplantation 1996;62(9):1278-85.
1996: David Porter; M S Roth; Sandra Lee; Carol McGarigle; James L M Ferrara; Joseph H Antin
Adoptive immunotherapy with donor mononuclear cell infusions to treat relapse of acute leukemia or myelodysplasia after allogeneic bone marrow transplantation.
Bone marrow transplantation 1996;18(5):975-80.
1996: Kenneth R Cooke; L Kobzik; T R Martin; J Brewer; J Delmonte; James M Crawford; James L M Ferrara
An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.
Blood 1996;88(8):3230-9.
1996: L Pan; S Bressler; Kenneth R Cooke; W Krenger; M Karandikar; James L M Ferrara
Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(3):126-33.
1996: James L M Ferrara; Kenneth R Cooke; L Pan; W Krenger
The immunopathophysiology of acute graft-versus-host-disease.
Stem cells (Dayton, Ohio) 1996;14(5):473-89.
1996: W Krenger; G Falzarano; J Delmonte; K M Snyder; J C Byon; James L M Ferrara
Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease.
Blood 1996;88(3):1113-21.
1996: IJ Rimm; W Krenger; JL Beland; M C Geller; E Di Savino; K Yui; M Katsumata; James L M Ferrara
TCR-beta transgenic mice fail to mediate a GVHR due to defects of allorecognition and subsequent IL-2 generation.
Bone marrow transplantation 1996;17(5):835-42.
1996: K N Tan; H K Min; L Pan; James L M Ferrara; K V Myrick
Biological characteristics of an immunoregulatory activity secreted by an autoreactive CD4+ T cell clone that suppresses autoimmune diabetes in non-obese diabetic mice.
International immunology 1996;8(5):689-99.
1996: G Falzarano; W Krenger; K M Snyder; J Delmonte; M Karandikar; James L M Ferrara
Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease.
Blood 1996;87(7):2853-60.
1996: W Krenger; James L M Ferrara
Dysregulation of cytokines during graft-versus-host disease.
Journal of hematotherapy 1996;5(1):3-14.
1996: W Krenger; James L M Ferrara
Graft-versus-host disease and the Th1/Th2 paradigm.
Immunologic research 1996;15(1):50-73.
1995: James L M Ferrara
Cytokine inhibitors and graft-versus-host disease.
Annals of the New York Academy of Sciences 1995;770():227-36.
1995: L Pan; J Delmonte; C K Jalonen; James L M Ferrara
Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease.
Blood 1995;86(12):4422-9.
1995: W Krenger; K M Snyder; J C Byon; G Falzarano; James L M Ferrara
Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(2):585-93.
1995: I Akhtar; J P Gold; L Y Pan; James L M Ferrara; X D Yang; J I Kim; K N Tan
CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice.
The Journal of experimental medicine 1995;182(1):87-97.
1995: James L M Ferrara
The febrile platelet transfusion reaction: a cytokine shower.
Transfusion 1995;35(2):89-90.
1994: W Krenger; K Snyder; S Smith; James L M Ferrara
Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
Transplantation 1994;58(11):1251-7.
1994: James L M Ferrara
Cellular and molecular mechanisms of graft-versus-host disease.
Transfusion science 1994;15(3):197-206.
1994: IJ Rimm; David A Fruman; S Abhyankar; H Sakamoto; I M Orme; D Milstone; J G Seidman; James L M Ferrara
T cell receptor (beta chain) transgenic mice have selective deficits in gamma delta T cell subpopulations.
Transplant immunology 1994;2(3):218-24.
1994: James L M Ferrara
Paradigm shift for graft-versus-host disease.
Bone marrow transplantation 1994;14(2):183-4.
1994: R B Wilson; James L M Ferrara; H J Baum; R C Shaler
Guidelines for internal validation of the HLA-DQ alpha DNA typing system.
Forensic science international 1994;66(1):9-22.
1994: S Neben; D Donaldson; Colin A Sieff; Peter M Mauch; D Bodine; James L M Ferrara; J Yetz-Aldape; K Turner
Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture.
Experimental hematology 1994;22(4):353-9.
1994: James L M Ferrara
Cytokines other than growth factors in bone marrow transplantation.
Current opinion in oncology 1994;6(2):127-34.
1994: David Porter; M S Roth; Carol McGarigle; James L M Ferrara; Joseph H Antin
Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.
The New England journal of medicine 1994;330(2):100-6.
1993: S Abhyankar; D G Gilliland; James L M Ferrara
Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens.
Transplantation 1993;56(6):1518-23.
1993: James L M Ferrara
Cytokine dysregulation as a mechanism of graft versus host disease.
Current opinion in immunology 1993;5(5):794-9.
1993: James L M Ferrara; S Abhyankar; D G Gilliland
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Transplantation proceedings 1993;25(1 Pt 2):1216-7.
1993: S Neben; S Hellman; M Montgomery; James L M Ferrara; Peter M Mauch; S Hemman
Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Experimental hematology 1993;21(1):156-62.
1993: D J Araten; T Lawton; James L M Ferrara; Joseph H Antin; E Milford; Charles B Carpenter; Richard T Maziarz
In vitro alloreactivity against host antigens in an adult HLA-mismatched bone marrow transplant recipient despite in vivo host tolerance.
Transplantation 1993;55(1):76-82.
1992: Joseph H Antin; James L M Ferrara
Cytokine dysregulation and acute graft-versus-host disease.
Blood 1992;80(12):2964-8.
1992: Julian D Down; Peter M Mauch; M Warhol; S Neben; James L M Ferrara
The effect of donor T lymphocytes and total-body irradiation on hemopoietic engraftment and pulmonary toxicity following experimental allogeneic bone marrow transplantation.
Transplantation 1992;54(5):802-8.
1992: James L M Ferrara
Advances in GVHD: novel lymphocyte subsets and cytokine dysregulation.
Bone marrow transplantation 1992;10 Suppl 1():10-2.
1991: H Sakamoto; J Michaelson; W K Jones; A K Bhan; S Abhyankar; M Silverstein; David E Golan; Steven J Burakoff; James L M Ferrara
Lymphocytes with a CD4+ CD8- CD3- phenotype are effectors of experimental cutaneous graft-versus-host disease.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(23):10890-4.
1991: P J van Dijken; J Wimperis; J M Crawford; James L M Ferrara
Effect of graft-versus-host disease on hematopoiesis after bone marrow transplantation in mice.
Blood 1991;78(10):2773-9.
1991: P L McCarthy; S Abhyankar; S Neben; G Newman; Colin A Sieff; R C Thompson; Steven J Burakoff; James L M Ferrara
Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease.
Blood 1991;78(8):1915-8.
1991: Joseph H Antin; B E Bierer; Brian R Smith; James L M Ferrara; Eva C Guinan; Colin A Sieff; David E Golan; R M Macklis; Nancy J Tarbell; E Lynch
Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies.
Blood 1991;78(8):2139-49.
1991: James L M Ferrara; H J Deeg
Graft-versus-host disease.
The New England journal of medicine 1991;324(10):667-74.
1991: IJ Rimm; T Ghayur; D L Gasser; K Rosenkrantz; Steven J Burakoff; Jonathan G Seidman; James L M Ferrara
Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(4):1130-3.
1990: D D Blatter; J M Crawford; James L M Ferrara
Nuclear magnetic resonance of hepatic graft-versus-host disease in mice.
Transplantation 1990;50(6):1011-8.
1990: P J van Dijken; T Ghayur; Peter M Mauch; Julian D Down; Steven J Burakoff; James L M Ferrara
Evidence that anti-LFA-1 in vivo improves engraftment and survival after allogeneic bone marrow transplantation.
Transplantation 1990;49(5):882-6.
1990: James L M Ferrara; Peter M Mauch; P J Van Dijken; K E Crosier; J Michaelson; Steven J Burakoff
Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients.
Transplantation 1990;49(1):134-8.
1990: Joseph H Antin; B E Bierer; Brian R Smith; Eva C Guinan; M M Provost; James L M Ferrara; R M Macklis; Nancy J Tarbell; H Blythman; C Bouloux
Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease.
Progress in clinical and biological research 1990;333():207-15.
1989: Peter M Mauch; James L M Ferrara; S Hellman
Stem cell self-renewal considerations in bone marrow transplantation.
Bone marrow transplantation 1989;4(6):601-7.
1989: Stephen G Emerson; S Thomas; James L M Ferrara; J L Greenstein
Developmental regulation of erythropoiesis by hematopoietic growth factors: analysis on populations of BFU-E from bone marrow, peripheral blood, and fetal liver.
Blood 1989;74(1):49-55.
1989: Julian D Down; A J Berman; M Warhol; P J Van Dijken; James L M Ferrara; B Yeap; S Hellman; Peter M Mauch
Late tissue-specific toxicity of total body irradiation and busulfan in a murine bone marrow transplant model.
International journal of radiation oncology, biology, physics 1989;17(1):109-16.
1989: D A Wall; S Hamberg; James L M Ferrara; Abul K Abbas
Immunodeficiency in graft-versus-host disease (GVHD). II. Effects of GVHD-induced suppressor cells on CD4+ T cell clones.
Journal of immunology (Baltimore, Md. : 1950) 1989;143(1):74-8.
1989: R M Macklis; W D Kaplan; James L M Ferrara; R W Atcher; J J Hines; Steven J Burakoff; C Norman Coleman
Alpha particle radio-immunotherapy: animal models and clinical prospects.
International journal of radiation oncology, biology, physics 1989;16(6):1377-87.
1989: James L M Ferrara; F J Guillen; P J van Dijken; A Marion; G F Murphy; Steven J Burakoff
Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease.
Transplantation 1989;47(1):50-4.
1988: R M Macklis; W D Kaplan; James L M Ferrara; B M Kinsey; Amin I Kassis; Steven J Burakoff
Biodistribution studies of anti-Thy 1.2 IgM immunoconjugates: implications for radioimmunotherapy.
International journal of radiation oncology, biology, physics 1988;15(2):383-9.
1988: R M Macklis; B M Kinsey; Amin I Kassis; James L M Ferrara; R W Atcher; J J Hines; C Norman Coleman; S James Adelstein; Steven J Burakoff
Radioimmunotherapy with alpha-particle-emitting immunoconjugates.
Science (New York, N.Y.) 1988;240(4855):1024-6.
1988: James L M Ferrara; J Michaelson; Steven J Burakoff; Peter M Mauch
Engraftment following T cell-depleted bone marrow transplantation. III. Differential effects of increased total-body irradiation on semiallogeneic and allogeneic recipients.
Transplantation 1988;45(5):948-52.
1988: D A Wall; S D Hamberg; D S Reynolds; Steven J Burakoff; Abul K Abbas; James L M Ferrara
Immunodeficiency in graft-versus-host disease. I. Mechanism of immune suppression.
Journal of immunology (Baltimore, Md. : 1950) 1988;140(9):2970-6.
1988: B M Kinsey; R M Macklis; James L M Ferrara; W W Layne; Steven J Burakoff; Amin I Kassis
Efficient conjugation of DTPA to an IgM monoclonal antibody in ascites fluid.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1988;15(3):285-92.
1987: R F Holcombe; W Strauss; F L Owen; Laurence A Boxer; R W Warren; M E Conley; James L M Ferrara; R Y Leavitt; Anthony Fauci; B A Taylor
Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man.
Genomics 1987;1(3):287-91.
1987: James L M Ferrara; Peter M Mauch; J McIntyre; J Michaelson; Steven J Burakoff
Engraftment following T-cell-depleted bone marrow transplantation. II. Stability of mixed chimerism in semiallogeneic recipients after total-body irradiation.
Transplantation 1987;44(4):495-9.
1987: James L M Ferrara
Syngeneic graft-vs-host disease.
Archives of dermatology 1987;123(6):741-2.
1987: James L M Ferrara; J P Daley; S J Burakoff; Richard A Miller
Functional T cell deficits after bone marrow transplantation across minor histocompatibility barriers: effects of graft-vs-host disease on precursor frequency of reactive cells.
Journal of immunology (Baltimore, Md. : 1950) 1987;138(11):3598-603.
1987: James L M Ferrara; Jeffrey Lipton; S Hellman; Steven J Burakoff; Peter M Mauch
Engraftment following T-cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers.
Transplantation 1987;43(4):461-7.
1987: James L M Ferrara; A Marion; G Murphy; Steven J Burakoff
Acute graft-versus-host disease: pathogenesis and prevention with a monoclonal antibody in vivo.
Transplantation proceedings 1987;19(1 Pt 3):2662-3.
1986: James L M Ferrara; A Marion; J F McIntyre; G F Murphy; Steven J Burakoff
Amelioration of acute graft vs host disease due to minor histocompatibility antigens by in vivo administration of anti-interleukin 2 receptor antibody.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(6):1874-7.
1986: F J Guillén; James L M Ferrara; W W Hancock; D Messadi; E Fonferko; S J Burakoff; GEORGE MURPHY
Acute cutaneous graft-versus-host disease to minor histocompatibility antigens in a murine model. Evidence that large granular lymphocytes are effector cells in the immune response.
Laboratory investigation; a journal of technical methods and pathology 1986;55(1):35-42.
1986: James L M Ferrara; F J Guillen; Barry P Sleckman; S J Burakoff; G F Murphy
Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease.
The Journal of investigative dermatology 1986;86(4):371-5.
1985: Brian R Smith; Eva C Guinan; R Parkman; James L M Ferrara; R H Levey; David G Nathan; J M Rappeport
Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia.
Transplantation 1985;39(6):671-3.
1985: James L M Ferrara; Peter M Mauch; G Murphy; S J Burakoff
Bone marrow transplantation: the genetic and cellular basis of resistance to engraftment and acute graft-versus-host disease.
Survey of immunologic research 1985;4(4):253-63.